NextPlat Corp Segments Disclosure
Note 20. Reportable Segments
The Company has reportable segments: (i) e-Commerce Operations, which involves acquiring and leasing, primarily an e-commerce platform to collaborate with businesses to optimize their ability to sell their goods online, domestically, and internationally, and enabling customers and partners to optimize their e-commerce presence and revenue, and other related businesses and (ii) Healthcare Operations, which provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, compounded medications, telepharmacy services, anti-retroviral medications, medication therapy management, the supply of prescription medications to long-term care facilities, medication adherence packaging, contracted pharmacy services for 340B covered entities under the 340B Drug Discount Pricing Program, and health practice risk management. This organizational structure aligns with how the Company’s CODMs manage the business, including resource allocation and performance assessment, and further aligns with the Company’s product categories and the key markets the Company serves.
The CODMs include the Company’s Chief Executive Officer and Chief Financial Officer.
The CODMs do not review segment assets and segment expenses at a level different than what is reported in the Company’s Consolidated Balance Sheets and Consolidated Statements of Operations and Comprehensive Loss. While the Company believes there are synergies between the two reportable segments, the segments are managed separately because each requires different business strategies. Accounting policies associated with our operating segments are generally the same as those described in Note 1.
The following tables provide information about the Company’s reportable segments (in thousands):
| Year Ended December 31, 2025 | e-Commerce Operations | Healthcare Operations | Eliminations | Total | ||||||||||||
| e-Commerce revenue | $ | 14,608 | $ | — | $ | — | $ | 14,608 | ||||||||
| Pharmacy prescription and other revenue, net of PBM fees | — | 35,704 | — | 35,704 | ||||||||||||
| Pharmacy 340B contract revenue | — | 4,010 | — | 4,010 | ||||||||||||
| Revenues, net | 14,608 | 39,714 | — | 54,322 | ||||||||||||
| Expenses: | ||||||||||||||||
| Cost of revenue | 11,251 | 32,165 | — | 43,416 | ||||||||||||
| Selling, general and administrative | 2,958 | 3,085 | — | 6,043 | ||||||||||||
| Salaries, wages and payroll taxes | 2,905 | 7,802 | — | 10,707 | ||||||||||||
| Professional fees | 1,510 | 754 | — | 2,264 | ||||||||||||
| Depreciation and amortization | 278 | 262 | — | 540 | ||||||||||||
| Intangible asset amortization | 102 | — | — | 102 | ||||||||||||
| Loss on settlement of litigation | — | 250 | — | 250 | ||||||||||||
| Total expenses | 19,004 | 44,318 | — | 63,322 | ||||||||||||
| Operating loss | (4,396 | ) | (4,604 | ) | — | (9,000 | ) | |||||||||
| Interest expense | 7 | 57 | — | 64 | ||||||||||||
| Other expense | 434 | 965 | — | 1,399 | ||||||||||||
| Loss before income taxes | (4,837 | ) | (5,626 | ) | — | (10,463 | ) | |||||||||
| Income taxes | — | — | — | - | ||||||||||||
| Net loss | $ | (4,837 | ) | $ | (5,626 | ) | $ | — | $ | (10,463 | ) | |||||
| Year Ended December 31, 2024 | e-Commerce Operations | Healthcare Operations | Eliminations | Total | ||||||||||||
| e-Commerce revenue | $ | 13,791 | $ | — | $ | — | $ | 13,791 | ||||||||
| Pharmacy prescription and other revenue, net of PBM fees | — | 41,907 | — | 41,907 | ||||||||||||
| Pharmacy 340B contract revenue | — | 10,384 | — | 10,384 | ||||||||||||
| Revenues, net | 13,791 | 52,291 | — | 66,082 | ||||||||||||
| Expenses: | ||||||||||||||||
| Cost of revenue | 10,356 | 38,718 | — | 49,074 | ||||||||||||
| Selling, general and administrative | 2,907 | 3,272 | — | 6,179 | ||||||||||||
| Salaries, wages and payroll taxes | 3,599 | 9,704 | — | 13,303 | ||||||||||||
| Impairment loss | — | 13,653 | — | 13,653 | ||||||||||||
| Professional fees | 2,900 | 1,741 | (240 | ) | 4,401 | |||||||||||
| Depreciation and amortization | 438 | 350 | — | 788 | ||||||||||||
| Intangible asset amortization | 101 | 1,608 | — | 1,709 | ||||||||||||
| Total expenses | 20,301 | 69,046 | (240 | ) | 89,107 | |||||||||||
| Operating loss | (6,510 | ) | (16,755 | ) | 240 | (23,025 | ) | |||||||||
| Interest expense | 13 | 68 | — | 81 | ||||||||||||
| Other (income) expense | (647 | ) | (244 | ) | 240 | (651 | ) | |||||||||
| Loss before income taxes | (5,876 | ) | (16,579 | ) | — | (22,455 | ) | |||||||||
| Income taxes | (71 | ) | — | — | (71 | ) | ||||||||||
| Net loss | $ | (5,947 | ) | $ | (16,579 | ) | $ | — | $ | (22,526 | ) | |||||
| e-Commerce Operations | Healthcare Operations | Eliminations | Total | |||||||||||||
| Total assets as of December 31, 2025 | $ | 12,748 | $ | 14,717 | $ | — | $ | 27,465 | ||||||||
| Total assets as of December 31, 2024 | $ | 19,044 | $ | 18,033 | $ | — | $ | 37,077 | ||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 31, 2026 | Showing above |
| 2024 | Mar 24, 2025 | |
| 2023 | Apr 11, 2024 | |
About Segments Disclosures
Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.
Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.